2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine
![]() |
- $231.99 - $859
- Product name: 2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine
- CAS: 260045-66-7
- MF: C10H7Cl2N3
- MW: 240.09
- EINECS:
- MDL Number:MFCD11505047
- Synonyms:2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine;4-Pyrimidinamine, 2-chloro-N-(3-chlorophenyl)-
5 prices
Selected condition:
Brand
- AK Scientific
- Alichem
- Crysdot
- Matrix Scientific
Package
- 1g
- 5g
- ManufacturerAK Scientific
- Product number8573AD
- Product description2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine
- Packaging1g
- Price$460
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number260045667
- Product description2-Chloro-n-(3-chlorophenyl)pyrimidin-4-amine
- Packaging1g
- Price$231.99
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number260045667
- Product description2-Chloro-n-(3-chlorophenyl)pyrimidin-4-amine
- Packaging5g
- Price$621.72
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11157269
- Product description2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine 95+%
- Packaging5g
- Price$859
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number083977
- Product description2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine 97%
- Packaging1g
- Price$304
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8573AD | 2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine | 1g | $460 | 2021-12-16 | Buy |
Alichem | 260045667 | 2-Chloro-n-(3-chlorophenyl)pyrimidin-4-amine | 1g | $231.99 | 2021-12-16 | Buy |
Alichem | 260045667 | 2-Chloro-n-(3-chlorophenyl)pyrimidin-4-amine | 5g | $621.72 | 2021-12-16 | Buy |
Crysdot | CD11157269 | 2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine 95+% | 5g | $859 | 2021-12-16 | Buy |
Matrix Scientific | 083977 | 2-Chloro-N-(3-chlorophenyl)pyrimidin-4-amine 97% | 1g | $304 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|